Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes.
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes.
复制标题
骨髓增生异常综合征不同U2AF1突变类型的临床特征和生物学意义
DOI:
10.1002/gcc.22510
复制
发表时间:
2018-03
影响因子:
3.7
通讯作者:
Xiao, Zhijian
中科院分区:
文献类型:
--
作者:
Li, Bing;Liu, Jinqin;Jia, Yujiao;Wang, Jingya;Xu, Zefeng;Qin, Tiejun;Shi, Zhongxun;Song, Zhen;Peng, Shuailing;Huang, Huijun;Fang, Liwei;Zhang, Hongli;Pan, Lijuan;Hu, Naibo;Qu, Shiqiang;Zhang, Yue;Wu, Jian;Liu, Na;Ru, Kun;Huang, Gang;Xiao, Zhijian
U2AF1 mutations (U2AF1MT) occur commonly in myelodysplastic syndromes (MDS) without ring sideroblasts. The aim of this study was to investigate the clinical and biological implications of different U2AF1 mutation types in MDS. We performed targeted gene sequencing in a cohort of 511 MDS patients. Eighty‐six patients (17%) were found to have U2AF1MT, which occurred more common in younger patients (P = .001) and represented ancestral lesions in a substantial proportion (71%) of cases. ASXL1MT and isolated +8 were significantly enriched in U2AF1MT‐positive cases, whereas TP53MT, SF3B1MT, and complex karyotypes were inversely associated with U2AF1MT. U2AFS34 subjects were enriched for isolated +8 and were inversely associated with complex karyotypes. U2AF1MT was significantly associated with anemia, thrombocytopenia, and poor survival in both lower‐risk and higher‐risk MDS. U2AF1S34 subjects had more frequently platelet levels of <50 × 109/L (P = .043) and U2AF1Q157/U2AF1R156 subjects had more frequently hemoglobin concentrations at <80 g/L (P = .008) and more often overt fibrosis (P = .049). In conclusion, our study indicates that U2AF1MT is one of the earliest genetic events in MDS patients and that different types of U2AF1MT have distinct clinical and biological characteristics.
登录
查看更多内容
影响因子:
11.4
作者:
通讯作者:
--
影响因子:
30.8
作者:
Makishima H;Yoshizato T;Yoshida K;Sekeres MA;Radivoyevitch T;Suzuki H;Przychodzen B;Nagata Y;Meggendorfer M;Sanada M;Okuno Y;Hirsch C;Kuzmanovic T;Sato Y;Sato-Otsubo A;LaFramboise T;Hosono N;Shiraishi Y;Chiba K;Haferlach C;Kern W;Tanaka H;Shiozawa Y;Gómez-Seguí I;Husseinzadeh HD;Thota S;Guinta KM;Dienes B;Nakamaki T;Miyawaki S;Saunthararajah Y;Chiba S;Miyano S;Shih LY;Haferlach T;Ogawa S;Maciejewski JP
通讯作者:
Maciejewski JP
影响因子:
8.8
作者:
McKerrell T;Park N;Moreno T;Grove CS;Ponstingl H;Stephens J;Understanding Society Scientific Group;Crawley C;Craig J;Scott MA;Hodkinson C;Baxter J;Rad R;Forsyth DR;Quail MA;Zeggini E;Ouwehand W;Varela I;Vassiliou GS
通讯作者:
Vassiliou GS
DOI:
10.1056/nejmoa1409405
发表时间:
2014-12-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Genovese G;Kähler AK;Handsaker RE;Lindberg J;Rose SA;Bakhoum SF;Chambert K;Mick E;Neale BM;Fromer M;Purcell SM;Svantesson O;Landén M;Höglund M;Lehmann S;Gabriel SB;Moran JL;Lander ES;Sullivan PF;Sklar P;Grönberg H;Hultman CM;McCarroll SA
通讯作者:
McCarroll SA
影响因子:
11.4
作者:
通讯作者:
--